Neonatal hepatitis syndrome

Seminars in Neonatology

Volumn 8, Issue 5, 2003, Pages 357-374

  Roberts, Eve A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Conjugated hyperbilirubinaemia; Giant cell hepatitis; Infant; Metabolic liver disease; Neonatal hepatitis syndrome; Neonatal liver failure

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; BILIRUBIN GLUCURONIDE; COLESTYRAMINE; PHENOBARBITAL; RETINOL; RIFAMPICIN; VITAMIN; VITAMIN D; VITAMIN K GROUP;

AUTOIMMUNE DISEASE; BILE DUCT ATRESIA; BILE DUCT MALFORMATION; BILIRUBIN BLOOD LEVEL; CHILD NUTRITION; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GENETIC DISORDER; HUMAN; HYPERBILIRUBINEMIA; HYPERNATREMIA; INFANT; INFECTION; INTESTINE OBSTRUCTION; INTOXICATION; JAUNDICE; LIVER TOXICITY; LIVER TRANSPLANTATION; METABOLIC DISORDER; NEOPLASM; NEWBORN; NEWBORN HEPATITIS; PALLIATIVE THERAPY; PHYSIOTHERAPY; PRURITUS; REVIEW; RICKETS; SEDATION; SIDE EFFECT; THROMBOCYTOPENIA; VASCULAR DISEASE;

EID: 0141894364     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00093-9     Document Type: Review

References (92)

1. Tomer G, Ananthanarayanan M, Weymann A et al. Differential developmental regulation of rat liver canalicular membrane transporters bsep and mrp2. Pediatr Res 2003;53:288-94.
2. Shneider BL. Neonatal liver failure. Curr Opin Pediatr 1996;8:495-501.
3. Jackson R, Roberts EA. Identification of neonatal liver failure and perinatal hemochromatosis in Canada. Paediatr Child Health 2001;6:248-50.
4. Lichtman S, Guzman C, Moore DL et al. Morbidity after percutaneous liver biopsy. Arch Dis Child 1987;62:901-4.
5. Chang MH, Huang HH, Huang ES et al. Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology 1992;103:1022-5.
6. Wolf MJ, Beunen G, Casaer P et al. Extreme hyperbilirubinaemia in Zimbabwean neonates: neurodevelopmental outcome at 4 months. Eur J Pediatr 1997;156:803-7.
7. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002;36:S106-13.
8. Persaud D, Bangaru B, Greco MA et al. Cholestatic hepatitis in children infected with the human immunodeficiency virus. Pediatr Infect Dis J 1993;12:492-8.
9. Silver MM, Hellmann J, Zielenska M et al. Anemia, blueberry-muffin rash, and hepatomegaly in a newborn infant. J Pediatr 1996;128:579-86.
10. Gillam GL, Stokes KB, McLellan J et al. Fulminant hepatic failure with intractable ascites due to an echovirus 11 infection successfully managed with a peritoneo-venous (LeVeen) shunt. J Pediatr Gastroenterol Nutr 1986;5:476-80.
11. Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics 2002;109:846-51.
12. Cantwell MF, Shehab ZM, Costello AM et al. Brief report: congenital tuberculosis. N Engl J Med 1994;330:1051-4.
13. Chardot C, Carton M, Spire-Bendelac N et al. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 1999;30:606-11.
14. Karrer FM, Hall RJ, Lilly JR. Biliary atresia and the polysplenia syndrome. J Pediatr Surg 1991;26:524-7.
15. Vasquez J, Lopez Gutierrez JC, Gamez M et al. Biliary atresia and the polysplenia syndrome: its impact on final outcome. J Pediatr Surg 1995;30:485-7.
16. Steele MI, Marshall CM, Lloyd RE et al. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995;21:697-702.
17. Bobo L, Ojeh C, Chiu D et al. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 1997;41:229-34.
18. Hart MH, Kaufman SS, Vanderhoof JA et al. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child 1991;145:302-5.
19. Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 1996;97:828-31.
20. Schreiber RA, Kleinman RE, Barksdale EM et al. Rejection of murine congenic bile ducts: a model for immune mediated bile duct disease. Gastroenterology 1992;102:924-30.
21. Stringer MD, Dhawan A, Davenport M et al. Choledochal cysts: lessons from a 20 year experience. Arch Dis Child 1995;73:528-31.
22. Amedee-Manesme O, Bernard O, Brunelle F et al. Sclerosing cholangitis with neonatal onset. J Pediatr 1987;111:225-9.
23. Mulberg AE, Arora S, Grand RJ et al. Expanding the spectrum of neonatal cholestatic liver disease. Hepatology 1992;16:192A.
24. Baker AJ, Portmann B, Westaby D et al. Neonatal sclerosing cholangitis in two siblings: a category of progressive intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1993;17:317-22.
25. Bar Meir M, Hadas-Halperin I, Fisher D et al. Neonatal sclerosing cholangitis associated with autoimmune phenomena. J Pediatr Gastroenterol Nutr 2000;30:332-4.
26. Connor SE, Hewes D, Ball C et al. Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst 2002;18:186-90.
27. Quiros-Tejeira RE, Ament ME, Heyman MB et al. Variable morbidity in Alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr 1999;29:431-7.
28. Deleuze JF, Dhorne-Pollet S, Pollet N et al. Alagille syndrome in 1995. Clinical and genetic data. Gastroenterol Clin Biol 1995;19:587-96.
29. Gilmour SM, Hershkop M, Reifen R et al. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med 1997;38:1279-82.
30. Silberbach M, Lashley D, Reller MD et al. Arteriohepatic dysplasia and cardiovascular malformations. Am Heart J 1991;127:695-9.
31. Brodsky MC, Cunniff C. Ocular anomalies in the Alagille syndrome (arteriohepatic dysplasia). Ophthalmology 1993;100:1767-74.
32. Holt RIG, Broide E, Buchman CR et al. Orthotopic liver transplantation reverse the adverse nutritional changes of end-stage liver disease in children. Am J Clin Nutr 1997;65:534-42.
33. Quiros-Tejeira RE, Ament ME, Heyman MB et al. Does liver transplantation affect growth pattern in Alagille syndrome? Liver Transpl 2000;6:582-7.
34. Spinner NB, Colliton RP, Crosnier C et al. Jagged1 mutations in Alagille syndrome. Hum Mutat 2001;17:18-33.
35. Crosnier C, Driancourt C, Raynaud N et al. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology 1999;116:1141-8.
36. Colliton RP, Bason L, Lu FM et al. Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat 2001;17:151-2.
37. Yuan ZR, Okaniwa M, Nagata I et al. The DSL domain in mutant JAG1 ligand is essential for the severity of the liver defect in Alagille syndrome. Clin Genet 2001;59:330-7.
38. Primhak RA, Tanner MS. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001;85:2-5.
39. Francavilla R, Castellaneta SP, Hadzic N et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 2000;32:986-92.
40. Prachalias AA, Kalife M, Francavilla R et al. Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int 2000;13:207-10.
41. Lykavieris P, Bernard O, Hadchouel M. Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch Dis Child 1996;75:67-70.
42. St-Louis M, Tanguay RM. Mutations in the fumarylaceto-acetate hydrotase gene causing hereditary tyrosinemia type I: overview. Hum Mutat 1997;9:291-9.
43. Holme E, Lindstedt S. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 1998;21:507-17.
44. Tolan DR. Molecular basis of hereditary fructose intolerance: mutations and polymorphisms in the human aldolase B gene. Hum Mutat 1995;6:210-8.
45. Esposito G, Vitagliano L, Santamaria R et al. Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett 2002;531:152-6.
46. Neufeld EB, Wastney M, Patel S et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple tysosomal cargo. J Biol Chem 1999;274:9627-35.
47. Sequeira JS, Vellodi A, Vanier MT et al. Niemann-Pick disease type C and defective peroxisomal beta-oxidation of branched-chain substrates. J Inherit Metab Dis 1998;21:149-54.
48. Kelly DA, Portmann B, Mowat AP et al. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr 1993;123:242-7.
49. Jacquemin E, Dumont M, Bernard O et al. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr 1994;153:424-8.
50. Bull LN, van Eijk MJ, Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-24.
51. Klomp LW, Bull LN, Knisely AS et al. A missense mutation in FIC1 is associated with Greenland familial cholestasis. Hepatology 2000;32:1337-41.
52. Bull LNCV, Stricker NL, Baharloo S et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-64.
53. van Ooteghem NA, Klomp LW, van Berge-Henegouwen GP et al. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT chotestasis is a clinical continuum. J Hepatol 2002;36:439-43.
54. Jansen PL, Strautnieks SS, Jacquemin E et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999;117:1370-9.
55. Wang L, Soroka CJ, Boyer JL. The role of bile salt export pump mutations in progressive familiar intrahepatic chotestasis type II. J Clin Invest 2002;110:965-72.
56. Jacquemin E, de Vree JML, Sturm E et al. Mutations in the MDR3 gene are responsible for a subtype of progressive familial intrahepatic cholestasis (PFIC) [abstr]. Hepatology 1997;26:248A.
57. Jacquemin E, De Vree JM, Cresteil D et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448-58.
58. Weber AM, Tuchweber B, Yousef I et al. Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction? Gastroenterology 1981;81:653-62.
59. Drouin E, Russo P, Tuchweber B et al. North American Indian cirrhosis in children: a review of 30 cases. J Pediatr Gastroenterol Nutr 2000;31:395-404.
60. Chagnon P, Michaud J, Mitchell G et al. A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. Am J Hum Genet 2002;71:1443-9.
61. Bull LN, Roche E, Song EJ et al. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet 2000;67:994-9.
62. Bove KE. Liver disease caused by disorders of bile acid synthesis. Clin Liver Dis 2000;4:831-48.
63. Clayton PT, Casteels M, Mieli-Vergani G et al. Familial giant cell hepatitis with low bile acid concentration and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis? Pediatr Res 1995;37:424-31.
64. Setchell KD, Schwarz M, O'Connell NC et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998;102:1690-703.
65. Setchell KD, Heubi JE, Bove KE et al. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology 2003;124:217-32.
66. Moser HW. Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol Genet Metab 1999;68:316-27.
67. Gould SJ, Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet 2000;16:340-5.
68. Preuss N, Brosius U, Biermanns M et al. PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr Res 2002;51:706-14.
69. Knisely AS, Magid MS, Dische MR et al. Neonatal hemochromatosis. Birth Defects 1987;22:75-102.
70. Vohra P, Haller C, Emre S et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr 2000;136:537-41.
71. Kelly AL, Lunt PW, Rodrigues F et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610.
72. Silver MM, Valberg LS, Lines LD et al. Tissue iron and copper quantitation in perinatal hemochromatosis and other perinatal liver diseases. Comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol 1993;143:1312-25.
73. Flynn DM, Mohan N, McKiernan P et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003;88:F124-7.
74. Bale PM, Kan AE, Dorney SF. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol 1994;14:479-89.
75. Ben-Shalom E, Kobayashi K, Shaag A et al. Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol Genet Metab 2002;77:202-8.
76. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 2002;47:333-41.
77. Tamamori A, Okano Y, Ozaki H et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 2002;161:609-13.
78. Kartenbeck J, Leuschner U, Mayer R et al. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996;23:1061-6.
79. Paulusma CC, Kool M, Bosma PJ et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
80. Hashimoto K, Uchiumi T, Konno T et al. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome. Hepatology 2002;36:1236-45.
81. Keitel V, Nies AT, Brom M et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003;284:G165-74.
82. Regev RH, Stolar O, Raz A et al. Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid. J Perinat Med 2002;30:185-7.
83. Silveira TR, Salzano FM, Howard ER et al. Congenital structural abnormalities in biliary atresia: evidence for etiopathogenic heterogeneity and therapeutic implications. Acta Paediatr Scand 1991;80:1192-9.
84. Schwab M, Niemeyer C, Schwarzer U. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis. Med Pediatr Oncol 1998;31:159-65.
85. Al-Kasim F, Doyle JJ, Massey GV et al. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2002;24:9-13.
86. Silverman ED, Laxer RM. Neonatal lupus erythematosus. Rheum Dis Clin North Am 1997;23:599-618.
87. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109:E11.
88. Selander B, Cedergren S, Domanski H. A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement. Acta Paediatr 1998;87:105-7.
89. Suita S, Arima T, Ishii K et al. Fate of infants with neonatal hepatitis: pediatric surgeons dilemma. J Pediatr Surg 1992;27:696-9.
90. Pierro A, Koletzko B, Carnielli V et al. Resting energy expenditure in infants and children with extrahepatic biliary atresia. J Pediatr Surg 1989;24:534-8.
91. Gregorio GV, Batt CS, Mowat AP et al. Effect of rifampin in the treatment of pruritus in hepatic cholestasis. Arch Dis Child 1993;69:141-3.
92. Emerick KM, Whitington PF. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 2002;35:1501-6.